Genitourinary malignancies.
Michaelson
M Dror
MD
Department of Hematology/Oncology, Massachusetts General Hospital, Boston 02114, USA. dmichaelson1@partners.org
Smith
Matthew R
MR
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000188:drug therapy / Q000601:surgery; D002986:Clinical Trials as Topic; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000601:surgery; D016030:Kidney Transplantation; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy; D014184:Transplantation, Homologous; D014565:Urogenital Neoplasms / Q000188:drug therapy* / Q000276:immunology
D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents